Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Thursday that its fourth quarter revenues rose 21 percent year over year, in line with preliminary Q4 revenues reported in January.

For the three months ended Dec. 31, 2018, the company reported revenues of $19.4 million, up from $16.0 million in Q4 2017, and beating the analysts' consensus estimate of $19.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.